| |
|
2009
|
|
Top
|
|
Vol. 8
|
|
December December 2009 No. 12, p839
|
|
Prostate Cancer: Closing the Gap Between Science and Practice
|
|
November November 2009 No. 11, p821
|
|
Cancer-Induced Bone Disease: Current Insights and Future Perspectives for Urologists
|
|
November November 2009 No. 10, p785
|
|
Current Perspectives in Metastatic Renal Cell Carcinoma Treatment: The Role of mTOR Inhibitors
|
|
September September 2009 No. 9, p711
|
|
The 2nd World Congress on Controversies in Urology
|
|
September September 2009 No. 8, p567
|
|
Abstracts of EAU 3rd North Eastern European Meeting (NEEM), EAU 5th South Eastern European Meeting (SEEM), and EAU 9th Central European Meeting (CEM)
|
|
September September 2009 No. 7, p535
|
|
Incorporating the EAU-EBU Update Series
|
|
April April 2009 No. 6, p489
|
|
Incorporating the EAU-EBU Update Series
|
|
April April 2009 No. 5, p417
|
|
Update Uro-Oncology 2009
|
|
March March 2009 No. 4, p121
|
|
24th Annual Congress of the European Association of Urology
|
|
January January 2009 No. 3, p89
|
|
Changing Horizons in the Diagnosis and Therapy of Prostate Cancer: Preparing for the Future
|
|
January January 2009 No. 2, p47
|
|
Highlights of the 3rd Meeting of Experts in Sexual Medicine (REMS)
|
|
January January 2009 No. 1, p1
|
|
Exploring Issues and Unmet Needs in Hormone-Resistant Prostate Cancer A Satellite Symposium presented at the 23rd Congress of the European Association of Urology
|
|
|
2008
|
|
Top
|
|
Vol. 7
|
|
December December 2008 No. 13, p743
|
|
Hormone Therapy for Prostate Cancer: Less is More? Proceedings of the EAU 2008 Satellite Symposium
|
|
November November 2008 No. 12, p703
|
|
Incorporating the EAU-EBU Update Series
|
|
November November 2008 No. 11, p675
|
|
The Future of LUTS/BPH: Management beyond the Prostate
|
|
October October 2008 No. 10, p615
|
|
Approaches to the Management of Non-Muscle Invasive Bladder Cancer (NMIBC): A Review of Current Guidelines and Best Practice Recommendations from the International Bladder Cancer Group (IBCG)
|
|
September September 2008 No. 9, p577
|
|
Continued Progress in the Treatment of Advanced Renal Cell Carcinoma: an Update on the Role of Sunitinib
|
|
August August 2008 No. 8, p549
|
|
Incorporating the EAU-EBU Update Series
|
|
July July 2008 No. 7, p509
|
|
An Overview of Non-invasive Bladder Cancer: Epidemiology, Diagnosis, Treatment and Economics
|
|
April April 2008 No. 6, p457
|
|
Oncoforum Urology: Advances in Oncological Urology from EAU, AUA and ASCO 2007
|
|
April April 2008 No. 5, p393
|
|
Update Uro-Oncology 2008
|
|
April April 2008 No. 4, p361
|
|
GreenLight HPS Laser Therapy for BPH: Clinical Outcomes and Surgical Recommendations from the International GreenLight User Group (IGLU
|
|
March March 2008 No. 3, p71
|
|
23rd Annual Congress of the European Association of Urology
|
|
February February 2008 No. 2, p35
|
|
Multitargeted Therapy in Advanced Renal Cell Carcinoma: New Opportunities and Challenges for the Urologist
|
|
February February 2008 No. 1, p1
|
|
Multidisciplinary Management of the Prostate Cancer Patient
|
|
|
2007
|
|
Top
|
|
Vol. 6
|
|
November November 2007 No. 17, p859
|
|
Testosterone Deficiency Syndrome – Why Should We Urologists Be Involved?
|
|
October October 2007 No. 16, p847
|
|
Testosterone Associations with Erectile Dysfunction, Diabetes, and the Metabolic Syndrome MINI Supplement
|
|
September September 2007 No. 15, p817
|
|
Management of Prostate Cancer: Importance of Optimal Testosterone Control
|
|
August August 2007 No. 14, p787
|
|
New Insights in the Management of Non–Muscle-Invasive Bladder Cancer
|
|
July July 2007 No. 13, p761
|
|
Premature Ejaculation: Patients, Partners, Preconceptions, Promise. A Satellite Symposium during the 8th Congress of the European Society for Sexual Medicine. 5 December 2005, Copenhagen, Denmark
|
|
July July 2007 No. 12, p695
|
|
New Horizons in Urology: Applying New Insights and Technology into Clinical Practice
|
|
June June 2007 No. 11, p675
|
|
Skeletal Complications of Genitourinary Malignancies (Prostate, Renal, and Bladder) – Optimising Treatment with Bisphosphonates
|
|
May May 2007 No. 10, p601
|
|
New Frontiers in Renal Cell Cancer
|
|
April April 2007 No. 9, p573
|
|
Increasing the Patient's Energy: The Ultimate Goal in Managing LUTS/BPH?
|
|
March March 2007 No. 8, p511
|
|
Trends in Modern Management of Uro-oncological Diseases
|
|
March March 2007 No. 7, p475
|
|
Targeted Agents in the Management of Renal Cell Carcinoma: The Role of the Urologist. A Satellite Symposium to the 21st European Association of Urology Annual Congress, 7 April 2006, Paris, France
|
|
March March 2007 No. 6, p445
|
|
Facing the Current Challenges in Benign Prostatic Hyperplasia
|
|
March March 2007 No. 5, p423
|
|
OAB: What Matters to the Patient?
|
|
March March 2007 No. 4, p385
|
|
Oncoforum Urology: Advances in Oncologic Urology from EAU, AUA, ASCO and ASTRO 2006
|
|
March March 2007 No. 3, p325
|
|
Challenges in the Management of Urological Cancers
|
|
March March 2007 No. 2, p23
|
|
22nd Annual Congress of the European Association of Urology
|
|
January January 2007 No. 1, p1
|
|
Advancing the Management of OAB: New Data, New Directions
|
|
|
2006
|
|
Top
|
|
Vol. 5
|
|
December December 2006 No. 20, p989
|
|
Medical Therapy for BPH:What Factors Should We Consider?
|
|
November November 2006 No. 19, p911
|
|
UroLap 2005 Second International Urologic Workshop in Laparoscopy
|
|
November November 2006 No. 18, p887
|
|
Improving Management of Prostate Cancer: Are all LHRH Agonists Equal? Proceedings of the EAU 2006 symposium, 7 April 2006, Paris
|
|
October October 2006 No. 17, p871
|
|
Skeletal Preservation in Prostate Cancer: The Changing Role of the Urologist
|
|
October October 2006 No. 16, p835
|
|
Perspectives on Mixed Incontinence
|
|
September September 2006 No. 15, p811
|
|
Prostate Cancer: Optimising Treatment Strategy to Meet Our Patients' Needs. European Association of Urology (EAU) Annual Congress, Paris, 5–8 April 2006
|
|
September September 2006 No. 14, p787
|
|
Abstracts of the 17th Meeting of the European Society for Urological Research (ESUR)
|
|
September September 2006 No. 13, p759
|
|
Erectile Dysfunction and Sexual Satisfaction: New Perspectives
|
|
August August 2006 No. 12, p697
|
|
Examining the Forefront of Research and Clinical Practice in Prostate Disease. Prostate Health Forum - Today's Advances, Tomorrow's Clinical Practice. Vienna, Austria: October 14–15 2005
|
|
July July 2006 No. 11, p667
|
|
Botulinum Toxin in the Overactive Bladder: From Theory to Therapy Based on 'Botulinum Toxin in the Overactive ladder', an International Continence Society workshop, Montreal, 29 August 2005
|
|
July July 2006 No. 10, p647
|
|
An Integrated Approach to Preventing Progression in Superficial Bladder Cancer: Prognostic Factors, Optimal Treatment Regimens, and Side-Effect Management A Satellite Symposium of the 5th Annual Perspectives in Bladder Cancer
|
|
June June 2006 No. 9, p627
|
|
The Role of Finasteride in the Management of BPH and in the Prevention of Prostate Cancer
|
|
June June 2006 No. 8, p557
|
|
"Recitatio Artis Plena" on Kidney Cancer
|
|
April April 2006 No. 7, p537
|
|
Management of Prostate Cancer: Why is the Urologist's Role Changing? XXth European Association of Urology 2005 Symposium, 17 March 2005, Istanbul, Turkey
|
|
April April 2006 No. 6, p471
|
|
Technical Aspects of Urooncological Interventions Third Fall Meeting of the European Society of Oncological Urology (ESOU), 13-15 January 2006, Brussels, Belgium
|
|
April April 2006 No. 5, p441
|
|
Circumcaval Ureter: 2006 Update Celebrating the 20th Anniversary of the Department of Urology, Università Vita-Salute San Raffaele, Milan, Italy
|
|
April April 2006 No. 4, p399
|
|
New Insights in the Pathophysiology and Drug Management of Lower Urinary Symptoms Due to Benign Prostatic Enlargement: The Role of PermixonTM
|
|
April April 2006 No. 3, p359
|
|
Advances in Prostate and Bladder Cancer Management Proceedings from the symposium "New Horizons in Urology", Malta, 29-30 October, 2005
|
|
April April 2006 No. 2, p23
|
|
January January 2006 No. 1, p1
|
|
Expert Opinion on Hours of Undisturbed Sleep (HUS): A new tool to evaluate the impact of nocturia on LUTS/BPH patients
|
|
|
2005
|
|
Top
|
|
Vol. 4
|
|
November November 2005 No. 8, p1
|
|
Expert Report on Optimising Hormonal Control in Prostate Cancer
|
|
October October 2005 No. 7, p1
|
|
Omnic OCAS®: Proceedings of the European Launch Symposium, Reykjavik, Iceland, 11 February 2005
|
|
August August 2005 No. 6, p1
|
|
Would you recognize LOH if it walked into your practice? Diagnosis and management of late-onset hypogonadism
|
|
July July 2005 No. 5, p1
|
|
Prostate Cancer: Testosterone Suppression Levels and Eligard®
|
|
March March 2005 No. 4, p1
|
|
Controversies in the Management of Bladder Cancer and Prostate Cancer
|
|
March March 2005 No. 3, p3
|
|
XXth Congress of the European Association of Urology
|
|
February February 2005 No. 2, p1
|
|
OCAS: The Evolution of Tamsulosin for the Treatment of LUTS/BPH
|
|
January January 2005 No. 1, p1
|
|
Management of stress urinary incontinence in women: challenges and new perspectives
|
|
|
| |
|
